InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Cai Dong Chen, Executive. Director active across 2 companies, notably CSPC Pharmaceutical Group Ltd.. Cumulatively, 4 filings have been logged. Activity tracked since 26 March 2026. The latest transaction was filed on 22 June 2026 (Purchase). Regulator: HKEX. All data is accessible without signup.
4 of 4 declarations
Cai Dong Chen is an executive at CSPC Pharmaceutical Group Ltd. He is involved in the strategic management of the company, contributing to its development and competitiveness in the market. His responsibilities include overseeing operations and making important decisions for the company's performance. Cai Dong Chen plays a key role in the strategic direction of CSPC Pharmaceutical Group Ltd.